-
Aytu BioScience Receives $5M Investment To Further Expansion Plans, Enter 'Cough And Cold' Market
Monday, November 5, 2018 - 2:00pm | 335Micro-cap pharmaceutical company Aytu BioScience, Inc. (NASDAQ: AYTU) is responsible for global commercialization of products to treat low testosterone, insomnia and male infertility. What Happened On Monday, Aytu BioScience revealed its entry into the $3 billion cough and cold market, through...